Italian scientists from an organization called Corvelva have published results from their testing of the Priorix Tetra vaccine (Measles-Mumps-Rubella-Varicella – MMRV) produced by GlaxoSmithKline.

Their report claims that DNA re-sequencing testing shows that the MMRV vaccine produced from cell line MRC-5 (of fetal origin) had an entire human genome with all the chromosomes of a male individual.

“The human reference genome was found to be matched by 99.76% reads from vaccine DNA, that means nearly in all its entirety. The human fetal DNA presented in this vaccine is a single entire genome, that means the vaccine contains genomic DNA with all the chromosomes of a male individual (in fact MRC-5 originates from a male fetus).”

The researchers claim that variants of this human genomic DNA that were found in the Priorix lot for the MMRV vaccine have been found in “genes involved in cancer.”